These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 12365066)

  • 1. How can physicians and their patients with ALS decide to use the newly-available treatments to slow disease progression?
    Armon C
    Amyotroph Lateral Scler Other Motor Neuron Disord; 1999 Dec; 1(1):3-14. PubMed ID: 12365066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic advances: new hope for patients with ALS.
    Forshew DA
    Nurs Spectr (Wash D C); 1998 Dec; 8(25):12-4. PubMed ID: 10542672
    [No Abstract]   [Full Text] [Related]  

  • 3. Potential use of gabapentin and lamotrigine.
    Cory PR; Gidal Be
    Ann Pharmacother; 1995 Nov; 29(11):1160-1. PubMed ID: 8573963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic reversal of cortical hyperexcitability in patients with ALS.
    Caramia MD; Palmieri MG; Desiato MT; Iani C; Scalise A; Telera S; Bernardi G
    Neurology; 2000 Jan; 54(1):58-64. PubMed ID: 10636126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential treatment of amyotrophic lateral sclerosis with gabapentin: a hypothesis.
    Welty DF; Schielke GP; Rothstein JD
    Ann Pharmacother; 1995 Nov; 29(11):1164-7. PubMed ID: 8573965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of fasciculations in patients with amyotrophic lateral sclerosis with the use of gabapentin.
    Romano JG
    Arch Neurol; 1996 Aug; 53(8):716. PubMed ID: 8759976
    [No Abstract]   [Full Text] [Related]  

  • 7. New approaches to therapy of amyotrophic lateral sclerosis.
    Miller RG
    West J Med; 1998 Apr; 168(4):262-3. PubMed ID: 9584665
    [No Abstract]   [Full Text] [Related]  

  • 8. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cephalon's unusual NDA move.
    Nat Biotechnol; 1998 Jan; 16(1):8. PubMed ID: 9447581
    [No Abstract]   [Full Text] [Related]  

  • 10. ALS defeats gabapentin: reflections on another failed treatment.
    McDermott MP; Rowland LP
    Neurology; 2001 Apr; 56(7):826-7. PubMed ID: 11294916
    [No Abstract]   [Full Text] [Related]  

  • 11. Placebo-controlled trial of gabapentin in patients with amyotrophic lateral sclerosis. WALS Study Group. Western Amyotrophic Lateral Sclerosis Study Group.
    Miller RG; Moore D; Young LA; Armon C; Barohn RJ; Bromberg MB; Bryan WW; Gelinas DF; Mendoza MC; Neville HE; Parry GJ; Petajan JH; Ravits JM; Ringel SP; Ross MA
    Neurology; 1996 Dec; 47(6):1383-8. PubMed ID: 8960715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ALS defeats gabapentin: reflections on another failed treatment.
    Brigell MG; Taylor CP
    Neurology; 2001 Oct; 57(8):1524-5. PubMed ID: 11673613
    [No Abstract]   [Full Text] [Related]  

  • 13. Riluzole and edaravone: A tale of two amyotrophic lateral sclerosis drugs.
    Jaiswal MK
    Med Res Rev; 2019 Mar; 39(2):733-748. PubMed ID: 30101496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Cochrane Database Syst Rev; 2002; (2):CD001447. PubMed ID: 12076411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis.
    Gurney ME; Cutting FB; Zhai P; Doble A; Taylor CP; Andrus PK; Hall ED
    Ann Neurol; 1996 Feb; 39(2):147-57. PubMed ID: 8967745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Riluzole treatment in advanced ALS.
    Borasio GD
    J Neurol; 2002 May; 249(5):505-6. PubMed ID: 12021937
    [No Abstract]   [Full Text] [Related]  

  • 17. Evidence for a multimodal effect of riluzole in patients with ALS?
    de Jongh AD; van Eijk RPA; van den Berg LH
    J Neurol Neurosurg Psychiatry; 2019 Oct; 90(10):1183-1184. PubMed ID: 30846539
    [No Abstract]   [Full Text] [Related]  

  • 18. Slowing down ALS--is this good or bad?
    Munsat TL
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2001 Mar; 2 Suppl 1():S19-22. PubMed ID: 11465919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High dose vitamin E therapy in amyotrophic lateral sclerosis as add-on therapy to riluzole: results of a placebo-controlled double-blind study.
    Graf M; Ecker D; Horowski R; Kramer B; Riederer P; Gerlach M; Hager C; Ludolph AC; Becker G; Osterhage J; Jost WH; Schrank B; Stein C; Kostopulos P; Lubik S; Wekwerth K; Dengler R; Troeger M; Wuerz A; Hoge A; Schrader C; Schimke N; Krampfl K; Petri S; Zierz S; Eger K; Neudecker S; Traufeller K; Sievert M; Neundörfer B; Hecht M;
    J Neural Transm (Vienna); 2005 May; 112(5):649-60. PubMed ID: 15517433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Riluzole, neuroprotection and amyotrophic lateral sclerosis.
    Cheah BC; Vucic S; Krishnan AV; Kiernan MC
    Curr Med Chem; 2010; 17(18):1942-199. PubMed ID: 20377511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.